693 related articles for article (PubMed ID: 25732737)
21. Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.
Xiao J; Yang R; Biswas S; Qin X; Zhang M; Deng W
Int J Mol Sci; 2015 Apr; 16(5):9283-302. PubMed ID: 25918935
[TBL] [Abstract][Full Text] [Related]
22. The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties.
Gavasso S; Kråkenes T; Olsen H; Evjenth EC; Ytterdal M; Haugsøen JB; Kvistad CE
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338644
[TBL] [Abstract][Full Text] [Related]
23. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter?
Uccelli A; Morando S; Bonanno S; Bonanni I; Leonardi A; Mancardi G
Curr Stem Cell Res Ther; 2011 Mar; 6(1):69-72. PubMed ID: 20955153
[TBL] [Abstract][Full Text] [Related]
25. Comparative transcriptome analysis in induced neural stem cells reveals defined neural cell identities in vitro and after transplantation into the adult rodent brain.
Hallmann AL; Araúzo-Bravo MJ; Zerfass C; Senner V; Ehrlich M; Psathaki OE; Han DW; Tapia N; Zaehres H; Schöler HR; Kuhlmann T; Hargus G
Stem Cell Res; 2016 May; 16(3):776-81. PubMed ID: 27153350
[TBL] [Abstract][Full Text] [Related]
26. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Harris VK; Vyshkina T; Sadiq SA
Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE.
Rafieemehr H; Kheyrandish M; Soleimani M
Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):596-604. PubMed ID: 26725557
[TBL] [Abstract][Full Text] [Related]
28. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Wang D; Sun YQ; Gao WX; Fan XL; Shi JB; Fu QL
Cell Transplant; 2018 Sep; 27(9):1340-1351. PubMed ID: 30056763
[TBL] [Abstract][Full Text] [Related]
29. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.
Kawabata S; Takano M; Numasawa-Kuroiwa Y; Itakura G; Kobayashi Y; Nishiyama Y; Sugai K; Nishimura S; Iwai H; Isoda M; Shibata S; Kohyama J; Iwanami A; Toyama Y; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2016 Jan; 6(1):1-8. PubMed ID: 26724902
[TBL] [Abstract][Full Text] [Related]
30. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
31. Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration.
Orack JC; Deleidi M; Pitt D; Mahajan K; Nicholas JA; Boster AL; Racke MK; Comabella M; Watanabe F; Imitola J
Stem Cells Transl Med; 2015 Mar; 4(3):252-60. PubMed ID: 25593207
[TBL] [Abstract][Full Text] [Related]
32. Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis.
Mutukula N; Man Z; Takahashi Y; Iniesta Martinez F; Morales M; Carreon-Guarnizo E; Hernandez Clares R; Garcia-Bernal D; Martinez Martinez L; Lajara J; Nuñez Delicado E; Meca Lallana JE; Izpisua Belmonte JC
Stem Cell Res; 2021 May; 53():102319. PubMed ID: 33894548
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
34. Cell-based therapeutic strategies for multiple sclerosis.
Scolding NJ; Pasquini M; Reingold SC; Cohen JA; ; ;
Brain; 2017 Nov; 140(11):2776-2796. PubMed ID: 29053779
[TBL] [Abstract][Full Text] [Related]
35. Induced neural stem cells as a means of treatment in Huntington's disease.
Choi KA; Hong S
Expert Opin Biol Ther; 2017 Nov; 17(11):1333-1343. PubMed ID: 28792249
[TBL] [Abstract][Full Text] [Related]
36. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
37. Enrichment of Oligodendrocyte Progenitors from Differentiated Neural Precursors by Clonal Sphere Preparations.
Umebayashi D; Coles B; van der Kooy D
Stem Cells Dev; 2016 May; 25(9):712-28. PubMed ID: 26972950
[TBL] [Abstract][Full Text] [Related]
38. Stem Cell Therapy for Multiple Sclerosis.
Genc B; Bozan HR; Genc S; Genc K
Adv Exp Med Biol; 2019; 1084():145-174. PubMed ID: 30039439
[TBL] [Abstract][Full Text] [Related]
39. Induced neural stem cells achieve long-term survival and functional integration in the adult mouse brain.
Hemmer K; Zhang M; van Wüllen T; Sakalem M; Tapia N; Baumuratov A; Kaltschmidt C; Kaltschmidt B; Schöler HR; Zhang W; Schwamborn JC
Stem Cell Reports; 2014 Sep; 3(3):423-31. PubMed ID: 25241741
[TBL] [Abstract][Full Text] [Related]
40. An observational study of autologous bone marrow-derived stem cells transplantation in seven patients with nervous system diseases: a 2-year follow-up.
Ren C; Geng RL; Ge W; Liu XY; Chen H; Wan MR; Geng DQ
Cell Biochem Biophys; 2014 May; 69(1):179-87. PubMed ID: 24062130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
